{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:33:37Z","timestamp":1786372417368,"version":"build-2736575974"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005370","name":"Gates Cambridge Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000828","name":"Royal Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.peptides.2026.171507","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:21:13Z","timestamp":1783639273000},"page":"171507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of glicentin as a low-potency glucose-dependent insulinotropic polypeptide receptor agonist"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6777-1817","authenticated-orcid":false,"given":"Paula-Peace","family":"James-Okoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9387-026X","authenticated-orcid":false,"given":"Joss","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-0541","authenticated-orcid":false,"given":"Abigail","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-7866","authenticated-orcid":false,"given":"Suleiman","family":"Al-Sabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koi Ni","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-9612","authenticated-orcid":false,"given":"Graham","family":"Ladds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hornigold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2026.171507_bib1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of Incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.peptides.2026.171507_bib2","first-page":"912","article-title":"Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations","volume":"76","author":"Nauck","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2026.171507_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2026.171507_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2026.171507_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"V\u00e9niant","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s42255-025-01295-w","article-title":"GIPR-Ab\/GLP-1 peptide\u2013antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice","volume":"7","author":"Liu","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102006","article-title":"AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys","volume":"88","author":"Jensen","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib14","article-title":"GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys","volume":"2","author":"Lu","year":"2021","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib15","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3389\/fcell.2021.749607","article-title":"Loss of function glucose-dependent insulinotropic polypeptide receptor variants are associated with alterations in bmi, bone strength and cardiovascular outcomes","volume":"9","author":"Kizilkaya","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.peptides.2026.171507_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102298","article-title":"Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studies","volume":"103","author":"Roell","year":"2026","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170197","article-title":"GIP and the gut-bone axis \u2013 physiological, pathophysiological and potential therapeutic implications","volume":"125","author":"Stensen","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2026.171507_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41574-022-00783-3","article-title":"Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1","volume":"19","author":"Hammoud","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.peptides.2026.171507_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib20","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/endo.133.6.8243312","article-title":"Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain","volume":"133","author":"Usdin","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2026.171507_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/187152411798047771","article-title":"Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival","volume":"11","author":"Paratore","year":"2011","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(94)90016-7","article-title":"Gastric inhibitory polypeptide (GIP) binding sites in rat brain","volume":"15","author":"Kaplan","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2026.171507_bib23","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s42255-023-00931-7","article-title":"Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice","author":"Liskiewicz","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164921","article-title":"Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding","volume":"8","author":"Adriaenssens","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.peptides.2026.171507_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2018.12.001","article-title":"Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism","volume":"20","author":"Mroz","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s42255-025-01294-x","article-title":"GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice","volume":"7","author":"Gutgesell","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0167-4781(92)90054-4","article-title":"Molecular cloning of rat glucose-dependent insulinotropic peptide (GIP)","volume":"1132","author":"Higashimoto","year":"1992","journal-title":"Biochim. Biophys. Acta BBA - Gene Struct. Expr."},{"key":"10.1016\/j.peptides.2026.171507_bib29","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1073\/pnas.90.5.1992","article-title":"Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat","volume":"90","author":"Tseng","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2026.171507_bib30","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fendo.2025.1532076","article-title":"The role of GIPR in food intake control","volume":"16","author":"James-Okoro","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.peptides.2026.171507_bib31","article-title":"The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system","volume":"125","author":"Adriaenssens","year":"2020","journal-title":"Glucose-Depend. Insul. Polypept. GIP"},{"key":"10.1016\/j.peptides.2026.171507_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101945","article-title":"Stimulating intestinal GIP release reduces food intake and body weight in mice","volume":"84","author":"Lewis","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib33","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1523\/JNEUROSCI.4920-04.2005","article-title":"Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation","volume":"25","author":"Nyberg","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2026.171507_bib34","first-page":"131","article-title":"cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects","volume":"6","author":"Sondhi","year":"2006","journal-title":"Pharm. J."},{"key":"10.1016\/j.peptides.2026.171507_bib35","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jnr.21349","article-title":"Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain","volume":"85","author":"Nyberg","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.peptides.2026.171507_bib36","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.peptides.2026.171507_bib37","first-page":"182","article-title":"Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor","volume":"100","author":"Graham","year":"2018","journal-title":"Newer Pept. -Based Agents Treat. Patients Type 2 Diabetes"},{"key":"10.1016\/j.peptides.2026.171507_bib38","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1074\/jbc.RA118.005682","article-title":"Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP","volume":"294","author":"Chepurny","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25","author":"Svendsen","year":"2018","journal-title":"Cell. Rep."},{"key":"10.1016\/j.peptides.2026.171507_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126742","article-title":"\u03b2 Cell tone is defined by proglucagon peptides through cAMP signaling","volume":"4","author":"Capozzi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.peptides.2026.171507_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/pr.55.1.6","article-title":"International union of pharmacology. XXXV. The glucagon receptor family","volume":"55","author":"Mayo","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.peptides.2026.171507_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrd3859","article-title":"The GPCR Network: a large-scale collaboration to determine human GPCR structure and function","volume":"12","author":"Stevens","year":"2013","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.peptides.2026.171507_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acs.chemrev.6b00049","article-title":"Allostery and biased agonism at class B G protein-coupled receptors","volume":"117","author":"Wootten","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.peptides.2026.171507_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/jcs.03338","article-title":"\u03b2-arrestin signaling and regulation of transcription","volume":"120","author":"Ma","year":"2007","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.peptides.2026.171507_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2020.01.009","article-title":"Dawn of a new RAMPage","volume":"41","author":"Serafin","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2026.171507_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPS regulate the transport and ligand specificity of the calcitonin- receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2026.171507_bib47","doi-asserted-by":"crossref","first-page":"14731","DOI":"10.1074\/jbc.M112084200","article-title":"Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR\/RAMP heterodimeric receptors*","volume":"277","author":"Flahaut","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib48","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1074\/jbc.M115.688218","article-title":"Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties","volume":"291","author":"Watkins","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib50","doi-asserted-by":"crossref","unstructured":"Hay, D.L., Christopoulos, G., Christopoulos, A., and Sexton, P.M. (2004). Amylin receptors: Molecular composition and pharmacology. In, pp. 865\u2013867. https:\/\/doi.org\/10.1042\/BST0320865.","DOI":"10.1042\/BST0320865"},{"key":"10.1016\/j.peptides.2026.171507_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.121.000567","article-title":"AM833 is a novel agonist of calcitonin family G protein\u2013coupled receptors: pharmacological comparison with six selective and nonselective agonists","volume":"377","author":"Fletcher","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2026.171507_bib52","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","article-title":"Development of cagrilintide, a long-acting amylin analogue","volume":"64","author":"Kruse","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib53","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2026.171507_bib54","article-title":"RAMPs regulate signalling bias and internalisation of the GIPR","author":"Matthew","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.peptides.2026.171507_bib55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.apsb.2021.07.028","article-title":"Modulating effects of RAMPs on signaling profiles of the glucagon receptor family","volume":"12","author":"Shao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.peptides.2026.171507_bib56","first-page":"12","article-title":"The effects of RAMPs upon cell signalling","volume":"449","author":"Routledge","year":"2017","journal-title":"Pleiotropic GPCR Signal. Health Dis."},{"key":"10.1016\/j.peptides.2026.171507_bib57","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1074\/jbc.M511147200","article-title":"Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors","volume":"281","author":"Kuwasako","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib58","doi-asserted-by":"crossref","first-page":"21925","DOI":"10.1074\/jbc.M116.751362","article-title":"Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors","volume":"291","author":"Weston","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib59","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1074\/jbc.M413786200","article-title":"Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking","volume":"280","author":"Bomberger","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib60","doi-asserted-by":"crossref","unstructured":"Lorenzen, E., Dodig-Crnkovi\u0107, T., Kotliar, I.B., Pin, E., Ceraudo, E., Vaughan, R.D., Uhl\u00e8n, M., Huber, T., Schwenk, J.M., and Sakmar, T.P. Multiplexed analysis of the secretin-like GPCR-RAMP interactome. Sci. Adv. 5, eaaw2778. https:\/\/doi.org\/10.1126\/sciadv.aaw2778.","DOI":"10.1126\/sciadv.aaw2778"},{"key":"10.1016\/j.peptides.2026.171507_bib61","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1476-5381.2012.02202.x","article-title":"Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function","volume":"168","author":"Wootten","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib62","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1074\/jbc.M114.624601","article-title":"Modulation of glucagon receptor pharmacology by receptor activity-modifying protein-2 (RAMP2)*","volume":"290","author":"Weston","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2022.106022","article-title":"A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus","volume":"174","author":"Smith","year":"2022","journal-title":"Appetite"},{"key":"10.1016\/j.peptides.2026.171507_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110604","article-title":"Receptor activity\u2013modifying protein 3 enhances GLP-1-mediated insulin secretion","volume":"301","author":"Pearce","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib65","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/dom.12735","article-title":"Robust anti-obesity and metabolic effects of a dual GLP-1\/glucagon receptor peptide agonist in rodents and non-human primates","volume":"18","author":"Henderson","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib66","doi-asserted-by":"crossref","first-page":"19760","DOI":"10.1074\/jbc.M112.426288","article-title":"Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor","volume":"288","author":"Ravn","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171507_bib67","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/1087057114562715","article-title":"Use of the site-specific retargeting jump-in platform cell line to support biologic drug discovery","volume":"20","author":"Butler","year":"2015","journal-title":"SLAS Discov."},{"key":"10.1016\/j.peptides.2026.171507_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101772","article-title":"EndoC-\u03b2H5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion","volume":"76","author":"Blanchi","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/2211068215587915","article-title":"Acoustic dispensing preserves the potency of therapeutic peptides throughout the entire drug discovery workflow","volume":"21","author":"Naylor","year":"2016","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.peptides.2026.171507_bib70","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00125-017-4491-0","article-title":"Development and characterisation of a novel glucagon like peptide-1 receptor antibody","volume":"61","author":"Biggs","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2026.171507_bib71","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/en.2015-1011","article-title":"Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys","volume":"156","author":"Okamoto","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2026.171507_bib72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/dom.13075","article-title":"A first-in-human pharmacodynamic and pharmacokinetic study of a fully human anti-glucagon receptor monoclonal antibody in normal healthy volunteers","volume":"20","author":"Kostic","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib73","doi-asserted-by":"crossref","first-page":"24093","DOI":"10.1073\/pnas.1905561116","article-title":"RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis","volume":"116","author":"Mackie","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.peptides.2026.171507_bib74","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bph.13384","article-title":"N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor","volume":"173","author":"Hansen","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib75","doi-asserted-by":"crossref","first-page":"G608","DOI":"10.1152\/ajpgi.00024.2010","article-title":"Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut","volume":"298","author":"Fujita","year":"2010","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.peptides.2026.171507_bib76","first-page":"265","article-title":"Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1\u201330) and GIP(1\u201342) in high-fat fed mice","volume":"208","author":"Gault","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2026.171507_bib77","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.peptides.2026.171507_bib78","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00109-007-0167-4","article-title":"Pro-protein convertases in intermediary metabolism: islet hormones, brain\/gut hormones and integrated physiology","volume":"85","author":"Bataille","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib79","doi-asserted-by":"crossref","first-page":"308","DOI":"10.11613\/BM.2017.034","article-title":"Insights on glicentin, a promising peptide of the proglucagon family., P., & (.)., 27(2)","volume":"27","author":"Raffort","year":"2017","journal-title":"Biochem. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib80","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1210\/endo.140.3.6550","article-title":"Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in chinese hamster ovary cells*","volume":"140","author":"Montrose-Rafizadeh","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2026.171507_bib81","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/10799890903295150","article-title":"Glucagon receptor mediates calcium signaling by coupling to G\u03b1q\/11 and G\u03b1i\/o in HEK293 cells","volume":"29","author":"Xu","year":"2009","journal-title":"J. Recept. Signal. Transduct."},{"key":"10.1016\/j.peptides.2026.171507_bib82","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.cell.2016.05.023","article-title":"The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism","volume":"165","author":"Wootten","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2026.171507_bib83","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1073\/pnas.131200398","article-title":"Glucagon receptor activates extracellular signal-regulated protein kinase 1\/2 via cAMP-dependent protein kinase","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.peptides.2026.171507_bib84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1210\/endo.132.1.8380389","article-title":"The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37)","volume":"132","author":"Lu","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2026.171507_bib85","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1172\/JCI140046","article-title":"Gs\/Gq signaling switch in \u03b2 cells defines incretin effectiveness in diabetes","volume":"130","author":"Oduori","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2026.171507_bib86","first-page":"223","article-title":"G\u03b1i\/o-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later","volume":"763","author":"Brust","year":"2015","journal-title":"G Protein-Couple Recept. Pharmacol. Signal."},{"key":"10.1016\/j.peptides.2026.171507_bib87","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/mi.2.3.168","article-title":"Isoforms of mammalian adenylyl cyclase: multiplicities of signaling","volume":"2","author":"Sunahara","year":"2002","journal-title":"Mol. Interv."},{"key":"10.1016\/j.peptides.2026.171507_bib88","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1111\/bph.12716","article-title":"Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast","volume":"171","author":"Weston","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.107.120006","article-title":"Oxyntomodulin differentially affects glucagon-like peptide-1 receptor \u03b2-arrestin recruitment and signaling through G\u03b1 s","volume":"322","author":"Jorgensen","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2026.171507_bib90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1476-5381.2011.01687.x","article-title":"The structure and function of the glucagon-like peptide-1 receptor and its ligands","volume":"166","author":"Donnelly","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101181","article-title":"Spatiotemporal GLP-1 and GIP receptor signaling and trafficking\/recycling dynamics induced by selected receptor mono- and dual-agonists","volume":"49","author":"Novikoff","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.peptides.2026.171507_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102006","article-title":"AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys","volume":"88","author":"Jensen","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib94","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","article-title":"The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets","volume":"5","author":"El","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bph.13323","article-title":"Species-specific action of (Pro3)GIP \u2013 a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors","volume":"173","author":"Sparre-Ulrich","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib96","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1111\/bph.16478","article-title":"Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. an important drug discovery challenge","volume":"182","author":"Gasbjerg","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib97","series-title":"Medical Pharmacology and Therapeutics (Fifth Edition)","first-page":"3","article-title":"1 - Principles of pharmacology and mechanisms of drug action","author":"Waller","year":"2018"},{"key":"10.1016\/j.peptides.2026.171507_bib98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.109.160531","article-title":"Pharmacological Characterization of Human Incretin Receptor Missense Variants","volume":"332","author":"Fortin","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2026.171507_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106890","article-title":"The GIP receptor displays higher basal activity than the glp-1 receptor but does not recruit GRK2 or arrestin3 effectively","volume":"9","author":"Al-Sabah","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.peptides.2026.171507_bib100","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/dbi16-0068","article-title":"Single-molecule combinatorial therapeutics for treating obesity and diabetes","volume":"66","author":"Tsch\u00f6p","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2026.171507_bib101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2021.12.005","article-title":"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1\/GIP\/GCG receptor triagonist","volume":"34","author":"Bossart","year":"2022","journal-title":"Cell. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib103","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013hormone-receptor agonist retatrutide for obesity \u2014 a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib104","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist\u2013induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2026.171507_bib105","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/db21-0848","article-title":"GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior","volume":"71","author":"Samms","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2026.171507_bib106","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/endo.133.6.8243312","article-title":"Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain","volume":"133","author":"Usdin","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2026.171507_bib107","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s42255-025-01342-6","article-title":"Fluorescent GLP1R\/GIPR dual agonist probes reveal cell targets in the pancreas and brain","volume":"7","author":"de Bray","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib108","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/diab.44.10.1202","article-title":"Cloning, Functional Expression, and Chromosomal Localization of the Human Pancreatic Islet Glucose-Dependent Insulinotropic Polypeptide Receptor","volume":"44","author":"Gremlich","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2026.171507_bib109","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fphar.2024.1463313","article-title":"Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354","volume":"15","author":"Rees","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib110","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad028","article-title":"Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells","volume":"164","author":"Manchanda","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2026.171507_bib111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(95)01006-Z","article-title":"Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma","volume":"373","author":"Volz","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.peptides.2026.171507_bib112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1677\/jme.0.0100259","article-title":"Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7\u201336)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells","volume":"10","author":"Gallwitz","year":"1993","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.peptides.2026.171507_bib113","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0303-7207(92)90109-J","article-title":"Are ionic fluxes of pancreatic beta cells a target for gastric inhibitory polypeptide?","volume":"90","author":"Wahl","year":"1992","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.peptides.2026.171507_bib114","first-page":"409","article-title":"Chapter 15 Glucose-Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)","author":"McIntosh","year":"2009","journal-title":"Vitam. & Horm. (Acad. Press. )"},{"key":"10.1016\/j.peptides.2026.171507_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101550","article-title":"Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue","volume":"64","author":"Samms","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib116","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1111\/ejn.15376","article-title":"A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice","volume":"54","author":"Arrigoni","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.peptides.2026.171507_bib117","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.peptides.2011.05.022","article-title":"Shared and separate functions of the RAMP-based adrenomedullin receptors","volume":"32","author":"Kuwasako","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2026.171507_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175912","article-title":"Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1\/3 KO than in WT mice","volume":"955","author":"Leuthardt","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171507_bib119","doi-asserted-by":"crossref","first-page":"e3003","DOI":"10.1210\/clinem\/dgaa329","article-title":"The role of glicentin and oxyntomodulin in human metabolism: new evidence and new directions","volume":"105","author":"Perakakis","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153960","article-title":"Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?","volume":"100","author":"Kokkinos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.peptides.2026.171507_bib121","doi-asserted-by":"crossref","unstructured":"Hannes Manell, Johan Staaf, Levon Manukyan, Hjalti Kristinsson, Jing Cen, Rasmus Stenlid, Iris Ciba, Anders Forslund, and Peter Bergsten Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes. J. Clin. Endocrinol. Metab. 101, 1181\u20131189. https:\/\/doi.org\/10.1210\/jc.2015-3885.","DOI":"10.1210\/jc.2015-3885"},{"key":"10.1016\/j.peptides.2026.171507_bib122","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0004563217700172","article-title":"Decreased serum glicentin concentration in patients with severe and morbid obesity","volume":"55","author":"Raffort","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.peptides.2026.171507_bib123","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s11695-016-2493-5","article-title":"Fasting Circulating Glicentin Increases After Bariatric Surgery","volume":"27","author":"Raffort","year":"2017","journal-title":"Obes. Surg."},{"key":"10.1016\/j.peptides.2026.171507_bib124","doi-asserted-by":"crossref","first-page":"e1064","DOI":"10.1210\/clinem\/dgaa061","article-title":"Oxyntomodulin and glicentin may predict the effect of bariatric surgery on food preferences and weight loss","volume":"105","author":"Nielsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153997","article-title":"Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: evidence from two independent trials","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.peptides.2026.171507_bib126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/297156a0","article-title":"Glicentin inhibits gastric acid secretion in the rat","volume":"297","author":"Kirkegaard","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2026.171507_bib127","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00903352","article-title":"Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs","volume":"29","author":"Ohneda","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.peptides.2026.171507_bib128","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1365-2036.2001.01082.x","article-title":"Glicentin, an active enteroglucagon, has a significant trophic role on the small intestine but not on the colon in the rat","volume":"15","author":"Sasaki","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.peptides.2026.171507_bib129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF02934484","article-title":"Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro","volume":"32","author":"Myojo","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.peptides.2026.171507_bib130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1749-6632.1998.tb11244.x","article-title":"Effect of rat glicentin on intestinal adaptation in small intestine-resected rats","volume":"865","author":"HIROTANI","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2026.171507_bib131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/jpsu.2003.50126","article-title":"Effect of glicentin on gut mucosal growth in rats with jejunal and ileal Thiry-vella fistulas","volume":"38","author":"Hashimoto","year":"2003","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.peptides.2026.171507_bib132","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00383-007-1895-9","article-title":"Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes","volume":"23","author":"Chiba","year":"2007","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.peptides.2026.171507_bib133","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1620\/tjem.155.197","article-title":"Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas","volume":"155","author":"OHNEDA","year":"1988","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0026-0495(95)90288-0","article-title":"Insulinotropic action of human glicentin in dogs","volume":"44","author":"Ohneda","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.peptides.2026.171507_bib135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2982.2004.00628.x","article-title":"Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9\u201339)","volume":"17","author":"Ayachi","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.peptides.2026.171507_bib136","article-title":"Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R\/GIPR biased agonism yielding greater efficacy","volume":"6","author":"Rodriguez","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.peptides.2026.171507_bib137","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/dom.70427","article-title":"GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models","volume":"28","author":"Baumer-Harrison","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib138","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1016\/j.cell.2025.05.042","article-title":"GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity","volume":"188","author":"Motso","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2026.171507_bib139","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/dom.14315","article-title":"Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: a cross-sectional functional MRI study","volume":"23","author":"Perakakis","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.peptides.2026.171507_bib140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(98)00144-X","article-title":"Plasma glicentin in diabetic and gastrectomized patients","volume":"79","author":"Naito","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2026.171507_bib141","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2982.2004.00528.x","article-title":"Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine","volume":"16","author":"Pellissier","year":"2004","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.peptides.2026.171507_bib142","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1749-6632.2000.tb07015.x","article-title":"Distinctive Effects of Glicentin, GLP-1 and GLP-2 on adaptive response to massive distal small intestine resection in rats","volume":"921","author":"HIROTANI","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2026.171507_bib143","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1210\/endo.142.10.8430","article-title":"Oxyntomodulin Inhibits Food Intake in the Rat","volume":"142","author":"Dakin","year":"2001","journal-title":"Endocrinology"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978126000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978126000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:33:14Z","timestamp":1786368794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978126000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":143,"alternative-id":["S0196978126000446"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2026.171507","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of glicentin as a low-potency glucose-dependent insulinotropic polypeptide receptor agonist","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2026.171507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"171507"}}